Advocating for Pediatric Patients and Survivors
Advocating for Pediatric Patients and Survivors
The Leukemia & Lymphoma Society Office of Public Policy supports policies that break down barriers pediatric patients encounter when accessing care and accelerate the development of new treatments for childhood cancers.
“Advancing research in pediatric cancer and improving quality of life for childhood cancer survivors are at the core of LLS’s mission,” said Gwen L. Nichols, MD, LLS’s chief medical officer. “We work tirelessly to support less toxic, more effective pediatric cancer treatments for our smallest cancer fighters.”
- Gwen L. Nichols
Additional Information
Accelerating New Treatments for Pediatric Patients
When it comes to childhood cancers, regulators often approach kids as if they’re tiny adults. But the biology of pediatric cancers is typically distinct from adults’, making targeted research critical.
Promoting Access to Care for Young Survivors
Survivors of childhood cancer often experience physical and mental health needs for years after their active treatment ends. Compounded with other burdens like higher insurance premiums, denied coverage or penalties for missed student loan payments, and fertility preservation decisions, young patients face fallout for their cancer diagnoses that extend beyond physical repercussions.